ArticleProstate cancer and prostatic diseases2020

Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Results at 6 and 12 months from a retrospective multi-centric study.

Claudio Maurizio Pacella et al.PubMed ↗Publisher ↗

No numbers read from the abstract.